Product out-licensing

PharmIdea out-licensing product list

Active ingredient Form Dosage Contract manufacturing by PharmIdea Usage
Atosiban solution for injection

concentrate for solution for infusion

6.75 mg/0.9 ml

37.5 mg/5 ml

CMO PharmIdea Prevention of prematurity
Bortezomib powder for solution for injection 3.5 mg CMO PharmIdea Multiple myeloma
Carbetocin solution for injection 100 micrograms/ml CMO PharmIdea Prevention of postpartum hemorrhage
Caspofungin powder for concentrate for solution for infusion 50 mg

70 mg

N/A Antifungal infection
Dexmedetomidine concentrate for solution for infusion 200 µg/2 ml

400 µg/4 ml

1000 µg/10 ml

CMO PharmIdea Sedative and analgesic
Levosimendan ** concentrate for solution for infusion 2.5 mg/ml CMO PharmIdea Acute decompensated heart failure
Micafungin ** powder for concentrate for solution for infusion 50 mg

100 mg

CMO PharmIdea Antifungal infection
Pemetrexed powder for concentrate for solution for infusion 500 mg N/A Pleural mesothelioma and non-small cell lung cancer
Zoledronic acid concentrate for solution for infusion 4 mg/5ml CMO PharmIdea Tumor induced hypercalcaemia

** Products under development

High quality regulatory affairs Dossier according to the European CTD module 2-5 in English

The territory should be agreed case by case